The presentation featured pooled 48-week data from two multicenter, randomized Phase II studies (Phase IIa, NCT06115993; Phase IIb, NCT06550128) in HBeAg-negative chronic hepatitis B (CHB) patients ...
Ruzasvir has demonstrated highly potent and pan-genotypic antiviral activity in preclinical (picomolar range) and clinical studies. Ruzasvir has been administered to over 2,100 subjects at daily doses ...
Abstract: During the last three decades, the importance of the application software is tremendously increased. Every organization has automated all their day-to-day activities. For automation purpose ...
Abstract: This study presents an AI-driven framework for predicting transmission frequency in cables using magnetic field data, offering a modern alternative to conventional analytical methods. A ...
-Two poster presentations showcase best- and first-in-class potential of ALX2004, a novel, antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors -Robust body of preclinical ...
1University of British Columbia, Vancouver, BC, Canada.
Last week, Google announced it was working with the S.C. Office of Resilience and other partners to provide energy-efficiency upgrades in selected communities that would save residents between $545 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback